Advertisement

Topics

Minerva Neurosciences, Inc.: Minerva Neurosciences to Present at Jefferies 2017 London Healthcare Conference on November 15, 2017

09:04 EST 8 Nov 2017 | FinanzNachrichten

WALTHAM, Mass., 2017-11-08 15:00 CET (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat centr...

Original Article: Minerva Neurosciences, Inc.: Minerva Neurosciences to Present at Jefferies 2017 London Healthcare Conference on November 15, 2017

NEXT ARTICLE

More From BioPortfolio on "Minerva Neurosciences, Inc.: Minerva Neurosciences to Present at Jefferies 2017 London Healthcare Conference on November 15, 2017"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...